Qube Research & Technologies Ltd - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 160 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,202
-99.5%
6,021
-98.8%
0.00%
-100.0%
Q4 2022$1,256,890
+187.6%
502,756
+385.4%
0.01%
+133.3%
Q3 2022$437,000
+97.7%
103,585
+30.6%
0.00%
+50.0%
Q2 2022$221,000
-49.9%
79,297
+2.9%
0.00%
-50.0%
Q1 2022$441,000
+224.3%
77,081
+567.8%
0.00%
-33.3%
Q1 2020$136,000
-66.4%
11,543
-33.0%
0.01%
-53.8%
Q4 2019$405,00017,2300.01%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders